1. Home
  2. GEHC vs FCNCA Comparison

GEHC vs FCNCA Comparison

Compare GEHC & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEHC
  • FCNCA
  • Stock Information
  • Founded
  • GEHC 1892
  • FCNCA 1898
  • Country
  • GEHC United States
  • FCNCA United States
  • Employees
  • GEHC N/A
  • FCNCA N/A
  • Industry
  • GEHC Computer Software: Prepackaged Software
  • FCNCA Major Banks
  • Sector
  • GEHC Technology
  • FCNCA Finance
  • Exchange
  • GEHC Nasdaq
  • FCNCA Nasdaq
  • Market Cap
  • GEHC 28.1B
  • FCNCA 25.4B
  • IPO Year
  • GEHC N/A
  • FCNCA N/A
  • Fundamental
  • Price
  • GEHC $70.54
  • FCNCA $1,840.25
  • Analyst Decision
  • GEHC Strong Buy
  • FCNCA Buy
  • Analyst Count
  • GEHC 10
  • FCNCA 9
  • Target Price
  • GEHC $88.80
  • FCNCA $2,420.44
  • AVG Volume (30 Days)
  • GEHC 4.5M
  • FCNCA 85.3K
  • Earning Date
  • GEHC 04-30-2025
  • FCNCA 07-24-2025
  • Dividend Yield
  • GEHC 0.20%
  • FCNCA 0.42%
  • EPS Growth
  • GEHC 38.77
  • FCNCA N/A
  • EPS
  • GEHC 4.76
  • FCNCA 175.01
  • Revenue
  • GEHC $19,799,000,000.00
  • FCNCA $9,091,000,000.00
  • Revenue This Year
  • GEHC $5.12
  • FCNCA N/A
  • Revenue Next Year
  • GEHC $4.69
  • FCNCA $2.30
  • P/E Ratio
  • GEHC $14.82
  • FCNCA $10.56
  • Revenue Growth
  • GEHC 1.56
  • FCNCA N/A
  • 52 Week Low
  • GEHC $57.65
  • FCNCA $1,473.62
  • 52 Week High
  • GEHC $94.80
  • FCNCA $2,412.93
  • Technical
  • Relative Strength Index (RSI)
  • GEHC 49.53
  • FCNCA 45.43
  • Support Level
  • GEHC $68.22
  • FCNCA $1,800.46
  • Resistance Level
  • GEHC $72.00
  • FCNCA $1,856.78
  • Average True Range (ATR)
  • GEHC 1.66
  • FCNCA 32.55
  • MACD
  • GEHC -0.00
  • FCNCA -12.63
  • Stochastic Oscillator
  • GEHC 24.32
  • FCNCA 6.47

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: